Predicting left atrial thrombi in atrial fibrillation

Area of Science:

• Cardiology
• Medical Diagnostics
• Thrombosis Research

Background:

• Stroke prevention in atrial fibrillation (AF) necessitates accurate risk stratification for cardioembolic events.
• Identifying patients with left atrial appendage thrombus (LAAT) is crucial for guiding antithrombotic therapy.
• Existing risk scores may not optimally identify patients at high risk for LAAT and cardioembolism.

Purpose of the Study:

• To evaluate the predictive capability of the CHADS(2) score for LAAT in nonvalvular AF patients.
• To identify independent predictors of LAAT in nonvalvular AF.
• To develop and validate a novel scoring system for improved LAAT risk assessment.

Main Methods:

• Retrospective analysis of nonanticoagulated, nonvalvular AF patients with and without LAAT.
• Transesophageal echocardiography used to diagnose LAAT.
• Comparison of clinical characteristics, AF parameters, and CHADS(2) scores between cases and controls.

Main Results:

• The CHADS(2) score was significantly higher in patients with LAAT.
• Independent predictors of LAAT included heart failure, prior stroke/TIA, diabetes, permanent AF, AF duration, and spontaneous echocardiographic contrast.
• A novel scoring system demonstrated superior predictive power (C-index 0.90) compared to the CHADS(2) score (C-index 0.71).

Conclusions:

• The CHADS(2) score is a predictor of LAAT in AF patients.
• Specific components of the CHADS(2) score and echocardiographic findings are key predictors of LAAT.
• A refined scoring system incorporating predictive factors enhances the identification of AF patients at high cardioembolic risk.